Literature DB >> 8719465

Audit of referral and explant diagnoses in lung transplantation: a pathologic study of lungs removed for parenchymal disease.

S Stewart1, K McNeil, S A Nashef, F C Wells, T W Higenbottam, J Wallwork.   

Abstract

BACKGROUND: Lung transplantation is performed for an increasing range of pulmonary conditions in which the diagnosis is often clinical or based on limited biopsy material. Diagnosis may be made late in the course of the disease where specific features are no longer present. Posttransplantation complications and disease recurrence may relate to the primary disease, and accurate diagnosis is therefore essential. METHODS AND
RESULTS: A pathologic review of 183 explanted lungs over a 10-year period (heart-lung = 109, single lung = 65, double lung = 9) showed 29 significant discrepancies or additional features likely to effect outcome. The final pathologic diagnosis was cystic fibrosis (n = 66), emphysema (59), bronchiectasis (17), pulmonary fibrosis (19), sarcoidosis (10), Langerhans cell histiocytosis (3), pulmonary veno-occlusive disease (3), posttransplantation obliterative bronchiolitis (2), primary hemosiderosis (1), rheumatoid obliterative bronchiolitis (1), extrinsic allergic alveolitis (1), pneumoconiosis (1). Unsuspected diagnoses included tuberculosis (8) (four cases of which were active and in single lung recipients requiring antituberculous chemotherapy), sarcoidosis (9), (of which, six were unsuspected primary diagnoses and three were additional diagnoses), veno-occlusive disease (3), carcinoma (1), pneumoconiosis (1), and pulmonary fibrosis (2). Aspergillus infection (2) and bronchocentric granulomatosis (3) were found in patients with cystic fibrosis. One active tuberculosis case also showed an aspergilloma. Unsuspected infections requiring therapy in immunosuppressed patients and previously unsuspected sarcoidosis, which is known to recur in the graft, were the major novel diagnoses. Discrepancy rate was 12 of 65 in single lungs (19%) and 17 of 109 in heart-lungs (16%).
CONCLUSIONS: These results emphasize the need for accurate preoperative diagnosis especially when the similarly diseased native lung remains in situ.

Entities:  

Mesh:

Year:  1995        PMID: 8719465

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  Sepsis in the severely immunocompromised patient.

Authors:  Andre C Kalil; Steven M Opal
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

2.  Lung transplantation for aspiration-induced silicosis of the lung.

Authors:  Masayuki Chida; Hiroshi Fukuda; Osamu Araki; Motohiko Tamura; Hideo Umezu; Shinichiro Miyoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-03-28

3.  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Authors:  Keith M Wille; Nirmal S Sharma; Tejaswini Kulkarni; Matthew R Lammi; Joseph B Barney; S Christopher Bellot; Ryan S Cantor; David C Naftel; Enrique Diaz-Guzman; David C McGiffin
Journal:  Ann Am Thorac Soc       Date:  2014-11

4.  Clinico-pathological Analysis of the Lungs from Patients with Lung Transplantation in a Single Institute in Korea.

Authors:  Hyojin Kim; Yoon Kyung Jeon; Hyun Joo Lee; Young Tae Kim; Doo Hyun Chung
Journal:  J Korean Med Sci       Date:  2015-09-12       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.